ICAAC 45th

Title Content type
In Vitro Activity of the New Azole BAL4815 against Clinical Candida Isolates Comprising Resistant C. albicans and Less Susceptible Candida spp (click for details)
Efficacy, Safety, and Tolerability of three Different Dosing Regimens of BAL8557 Vs. Fluconazole in a Double-Blind, Randomized, Multicenter Trial for the Treatment of Esophageal Candidiasis in Immunocompromised Adults (click for details)
In vivo Efficacy of the triazole BAL8557 (BAL) Compared to Voriconazole (VOR), Itraconazole (ITC) and Caspofungin (CAS) By a New qPCR and Quantitative Culture in a Neutropenic Murine Model of Aspergillus flavus (click for details)
Dose Response Curves and Dose Fractionation Studies with BAL8557 in a Murine Model of Disseminated Candidiasis (click for details)
Antifungal Activity of BAL4815, a Novel Azole Against Dermatophytes and Emerging Non-Dermatophyte Fungi Including Zygomycetes (click for details)
In vitro activity of the new azole BAL4815 against clinical dermatophyte isolates (click for details)
Caspofungin (CAS) Induced Rise in Circulating Fungal Antigens in Patients with Proven Invasive Fungal Infection (IFI) (click for details)
Safety and Tolerability of Voriconazole (VRC) plus Caspofungin (CAS) in Solid Organ Transplant (SOT) Recipients with Invasive Aspergillosis (IA) (click for details)
Attenuated Activity of Amphotericin B (AMB), Itraconazole (ITZ), and Voriconazole (VOR) against Aspergillus fumigatus Hyphae (click for details)
Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Trichosporonosis (click for details)


Subscribe to ICAAC 45th